Vitiligo

Latest News

Exploring Afamelanotide for Vitiligo: Insights into the CUV 105 Phase 3 Clinical Trial
Exploring Afamelanotide for Vitiligo: Insights into the CUV 105 Phase 3 Clinical Trial

September 6th 2024

The study is actively recruiting participants at multiple sites across the US.

Oral Silymarin Plus Hair Follicle Transplantation Efficacious in Refractory Vitiligo
Oral Silymarin Plus Hair Follicle Transplantation Efficacious in Refractory Vitiligo

September 3rd 2024

Researchers Report Case of Patient With Mogamulizumab-Induced Vitiligo
Researchers Report Case of Patient With Mogamulizumab-Induced Vitiligo

September 3rd 2024

Prostaglandin Analogues, Phosphodiesterase Inhibitors Effective in Vitiligo as Monotherapy or Add-On Modalities
Prostaglandin Analogues, Phosphodiesterase Inhibitors Effective in Vitiligo as Monotherapy or Add-On Modalities

September 2nd 2024

Exploring Genetic Factors in Vitiligo and AA
Exploring Genetic Factors in Vitiligo and AA

August 29th 2024

Latest CME Events & Activities
© 2024 MJH Life Sciences

All rights reserved.